Rx Medicare

The United States will start human trials of an experimental vaccine for preventing the 2009 H1N1 influenza virus in August; the first study will involve 1,000 volunteer adults and children in 10 centres throughout the country.

Read More…

Related Posts

• CSL Biotherapies Announces Start Of U.S. H1N1 Vaccine Clinical Trials
• Swine Flu: NIAID Set To Launch Clinical Trials To Test 2009 H1N1 Influenza Vaccine Candidates
• Bharat Biotech Begins Phase I Clinical Trials Of HN-VAC – Its Cell Culture H1N1 Vaccine
• VaxInnate Licenses Recombinant H1N1 Pandemic Swine Flu Vaccine To Biological E.; Vaccine Could Become Available For Use In India This Year
• US H1N1 Swine Flu Vaccine Supply On Track To Hit 10 Million Increase Says CDC Director
• Potential Allergen In H1N1 Swine Flu Vaccine May Put Children At Risk-Only Phadia Reveals Both Presence And Severity Of The Allergy
• Get Smart About Swine Flu H1N1 Swine Flu Vaccine Influenza P
• Pharmacy Organisations Back H1N1 Swine Flu Vaccine
• Sinovac Reports Positive Preliminary Results For Clinical Trials Of H1N1 Vaccine
• FDA Recommends H1N1 For Inclusion In Next Year’s Flu Vaccine
• SciClone And Sigma-Tau Announce Additional Positive Results In Clinical Study Examining ZADAXIN’s Ability To Enhance Response To H1N1 Vaccine
• H1N1 Flu (Swine Flu) Still Spreading In Some Parts Of The World, But Cases Generally Falling, World Health Organization
• Symptoms of H1N1 (Swine Flu)
• SciClone And Sigma-Tau Announce Positive Preliminary Results In Clinical Study Examining ZADAXIN’S Ability To Enhance Response To H1N1 Vaccine
• Canada To Bridge Mexico’s H1N1 Flu Vaccine Requirements

Tags: august, efficacy, h1n1, human, start, swine, trials, vaccine

This entry was posted on Friday, July 24th, 2009 at 1:07 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.